Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET
Administering preventive HIV medications to high-risk groups could greatly reduce the number of individuals who receive positive STD tests for the infection, according to a new study. This approach could represent a cost-effective strategy if the medications are given to the right groups.
The Stanford University researchers who conducted the study said that the combination medication tenofovir-emtricitabine has been shown to cut a person's risk of being infected with HIV by up to 44 percent when taken daily. The drug could present major potential for curbing the number of people who contract the virus, but it may not make economic sense to provide it to everyone.
For the study, the team created economic models of the cost of providing the drug to people. They found that it made the greatest impact in HIV rates when administered to men who have sex with men. This group receives about half of all new HIV diagnoses each year.
"Adopting [the medication] for men who have sex with men at high risk of acquiring HIV, however, is an investment with good value that does not break the bank," said lead researcher Jessie Juusola.
Related Articles from Private MD:
News Categories:Advanced Lipid Treatment I Allergy Testing Anemia and RBC disorders Autoimmune Diseases Bariatric Lab Testing Blood and Blood Diseases Breast Cancer Detection and Tumor Markers Celiac Disease Testing Chlamydia Coagulation and blood clotting disorders Colon Diabetes DNA, Paternity and Genetic testing Drug Screening Environmental Toxin Testing Female Specific Tests Gastrointestinal Diseases General Health General Wellness Heart Health and Cholesterol Herpes HIV HIV monitoring/Treatment/Testing/Post Diagnos Hormones and Metabolism Infectious Diseases Infertility Testing-Male Infertitlity Hormone Testing Kidney Diseases Leukemia and WBC disorders Liver Liver Diseases Lyme Disease Male Specific Tests Menopause/Peri-Menopausal Diagnosis Musculoskeletal Diseases Organ Specific Testing Ovarian Prostate Sexually Transmitted Diseases Thyroid Diseases Transgender Hormone Testing-female to male Transgender Hormone Testing-Male to Female Vitamin D Deficiency-Diagnosis and Treatment
Visit the Health News Archive: Click Here
Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.Back to top